Structure Therapeutics Inc. Capital Expenditures Incurred but Not yet Paid
Structure Therapeutics Inc. (GPCR) reported Capital Expenditures Incurred but Not yet Paid of $321.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-06
- Structure Therapeutics Inc. capital expenditures incurred but not yet paid for the quarter ending 2023-12-31 was -$264.00K.
- Structure Therapeutics Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $894.00K.
- Structure Therapeutics Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $48.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $321.00K 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $894.00K 10-K · filed 2026-02-26 | |||
| 2023-12-31 | -$264.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $48.00K 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $312.00K 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |